-
Exclusion of Ranitidine From Premedication Regimens During Paclitaxel Treatment
Huntjens, D. W., Vanhommerig, J. W., van de Veen, W. & Crul, M., 18 Jan 2024, In: JAMA oncology. 10, 1, p. 131-132 2 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
Huntjens, D. W., Dijkstra, J. A., Verwiel, L. N., Slijkhuis, M., Elbers, P., Welkers, M. R. A., Veldkamp, A. I., Kuijvenhoven, M. A., de Leeuw, D. C., Abdullah-Koolmees, H., Kuipers, M. T. & Bartelink, I. H., 1 Jan 2023, In: Pharmaceutics. 15, 1, 163.Research output: Contribution to journal › Review article › Academic › peer-review
-
DPD testing before treatment with fluoropyrimidines in the Amsterdam UMCs: An evaluation of current pharmacogenetic practice
Martens, F. K., Huntjens, D. W., Rigter, T., Bartels, M., Bet, P. M. & Cornel, M. C., 28 Jan 2020, In: Frontiers in pharmacology. 10, January, p. 1-10 10 p., 1609.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
